MBOAT7-TMC4 rs641738 Is Not Associated With the Risk of Hepatocellular Carcinoma or Persistent Hepatitis B Infection

Peng Wang, Ying Li, Lu Li, Rong Zhong, Na Shen

Open source

DOI
10.3389/fonc.2021.639438
Published
2021-05-25
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2021.639438,
  title = {MBOAT7-TMC4 rs641738 Is Not Associated With the Risk of Hepatocellular Carcinoma or Persistent Hepatitis B Infection},
  author = {Peng Wang and Ying Li and Lu Li and Rong Zhong and Na Shen},
  year = {2021},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2021.639438},
  url = {https://doi.org/10.3389/fonc.2021.639438}
}

RIS

TY  - JOUR
TI  - MBOAT7-TMC4 rs641738 Is Not Associated With the Risk of Hepatocellular Carcinoma or Persistent Hepatitis B Infection
AU  - Peng Wang
AU  - Ying Li
AU  - Lu Li
AU  - Rong Zhong
AU  - Na Shen
PY  - 2021
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2021.639438
UR  - https://doi.org/10.3389/fonc.2021.639438
ER  - 

APA

Wang, P., Li, Y., Li, L., Zhong, R., & Shen, N. (2021). MBOAT7-TMC4 rs641738 Is Not Associated With the Risk of Hepatocellular Carcinoma or Persistent Hepatitis B Infection. Frontiers in Oncology. https://doi.org/10.3389/fonc.2021.639438

Source records